Colorectal Case 3
Prof. Stefan Seewald
GastroZentrum Hirslanden, Zurich
Disclaimer:
- NBI™, RDI™ and TXI™ Technologies are not intended to replace histopathological sampling as a means of diagnosis
- NBI™, RDI™ and TXI™ Technologies are 510(k) cleared in the United State. This case study is being furnished to provide example of NBI, RDI and TXI technology use. The CF-EZ1500DI used in this case is not available in the US market at this time, nor is there an established time for it’s release. The safety and effectiveness of this product and/or the use of these products has not yet been established in the United States market.
- The positions and statements made herein by Prof. Seewald are based on Prof. Seewald’s experiences, thoughts and opinions. As with any product, results may vary, and the techniques, instruments, and settings can vary from facility to facility. The content hereof should not be considered as a substitute for carefully reading all applicable labeling, including the Instructions for Use. Please thoroughly review the relevant user manual(s) for instructions, risks, warnings, and cautions. Techniques, instruments, and setting can vary from facility to facility. It is the clinician’s decision and responsibility in each clinical situation to decide which products, modes, medications, applications, and settings to use.
- The EVIS X1 endoscopy system is not designed for cardiac applications. Other combinations of equipment may cause ventricular fibrillation or seriously affect the cardiac function of the patient. Improper use of endoscopes may result in patient injury, infection, bleeding, and/or perforation. Complete indications, contraindications, warnings, and cautions are available in the Instructions for Use (IFU)
Scope:CF-EZ1500DI
Case:LST-NG
Organ: Colon
Patient information: M, 60
Medical history: Preventive colonoscopy
1. Lateral Spreading Tumor - non-granular type LST-NG in WLI
LST-NG spreading across a fold
2. LST-NG with TXI™ technology
In TXI™ technology, the margins of the lesions become more evident. Stool is slightly interfering with TXI imaging.
3. LST-NG in NBI™ technology
NBI™ technology allows for analysis of superficial vessel pattern but is highly affected by remaining stool. Effective use of NBI™ technology requires excellent bowel preparation and thorough flushing.
4. TXI™ technology after injection
After injection, TXI™ technology is delivering clear visibility of the demarcation line.
5. TXI™ technology during endoscopic resection
TXI™ technology is enhancing visibility of submucosal fibers and blood vessels in the submucosal space.
6. Bleeding spot with RDI
RDI™ technology is helping to identify bleeding spots and allows for precise coagulation.
Case video
Overall Comment
In the presented case, TXI™ technology was beneficial for delineation and resection. RDI™ technology was helpful for efficient coagulation of bleeding.
* Specifications, design and accessories are subject to change without any notice or obligation on the part of the manufacturer.
